Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jan 25, 2024
Earnings Roundup: TSLA, NEE, IBM, CMCSA, NOW
Image: The Model Y was the best-selling vehicle globally in 2023. Image Source: Tesla. Tesla missed fourth-quarter results, and while the firm continues to generate robust free cash flow with a solid net cash position, uncertainty surrounding the name looms. NextEra makes the cut for ESG investors, and its earnings outlook for the next few years remains robust, even if its dividend growth may slow. IBM is back in growth mode, and the firm is looking to capitalize on watsonx and generative AI. Comcast has a lot of things going for it, and the firm's robust free cash flow generation suggests that future dividend growth will be robust, despite its lofty net debt position. ServiceNow continues to deliver for investors, and it continues to grow at a robust pace. Jan 24, 2024
Earnings Roundup: NFLX, ASML, T, ABT
Image: Netflix’s substantially improved free cash flow has made it a clear winner in the streaming wars. Image Source: Netflix. Netflix has won the streaming wars and continues to throw off material free cash flow as it lands incremental deals, the latest for WWE Raw. ASML is one of the most prolific innovators in the semiconductor industry, and its quarterly net bookings in the fourth quarter reveal an exciting future, even as revenue is forecast to be flat in 2024. AT&T's earnings outlook for 2024 disappointed, and rising capital spending will pressure free cash flow in 2024. Dividend King Abbott Labs continues to drive strong organic growth rates, exclusive of COVID-19 related weakness, and we expect years of future dividend growth at the company. Jan 23, 2024
Earnings Roundup: LMT, PG, MMM, GE, JNJ, VZ
Lockheed Martin's backlog hits a new high. Procter & Gamble's gross margin surprises to the upside. 3M's bottom-line outlook for 2024 came in lower than expectations. We're excited about GE's split into two companies this year and are positive on GE Aerospace. Johnson & Johnson reaffirmed its outlook for 2024, while Verizon's free cash flow continues to improve. Jan 13, 2024
FedEx’s ESG Initiatives Are Refreshing Reminder of Great Companies Doing Things Right
Image Source: FedEx 2023 ESG Report. FedEx’s revenue outlook for the remainder of fiscal 2024 wasn’t great, and while the company is a key input to assessing the health of the U.S. economy, we’re not reading too much into the weakness. We find that FedEx is doing a great job with respect to its ESG initiatives across the board, and while we won’t be adding it to any newsletter portfolio at this time, the company’s efforts with respect to ESG are a refreshing reminder of the companies in our coverage universe that are doing things right. Jan 12, 2024
UnitedHealth Group Still a Free-Cash-Flow Generating Machine
Image: UnitedHealth Group continues to drive strong revenue and operating earnings performance. Image Source: UnitedHealth Group. On January 12, healthcare benefits provider UnitedHealth Group reported strong fourth-quarter 2023 results that showed revenue advancing 14% on a year-over-year basis thanks to strength at its UnitedHealthcare and Optum divisions, while earnings from operations advanced 11.6%. UnitedHealth is facing some temporary cost pressures in its business due to pent-up demand for discretionary procedures following the worst of the COVID-19 pandemic, but its net margin held up fine in the period, coming in at 5.8%, the same level a year ago. Management reaffirmed its previously-issued 2024 guidance, and we continue to like UnitedHealth Group as a key weighting in the Best Ideas Newsletter portfolio. Shares yield ~1.4% at the time of this writing. Jan 12, 2024
Dividend Increases/Decreases for the Week of January 12
Let's take a look at firms raising/lowering their dividends this week. Jan 11, 2024
Dividend King Leggett & Platt’s Payout May Be Worth the Risk
Image: Leggett & Platt has put together a long track record of consecutive annual dividend increases, but recent performance suggests that the dividend may be at risk in the longer run. Its 7.1% dividend yield may be worth the risk, however. Leggett & Platt has raised its dividend for more than 50 consecutive years, putting it in the coveted category of being a Dividend King. However, the bedding, flooring and textile product maker has fallen on some difficult times. The company sports a Dividend Cushion ratio of -1.2 (negative 1.2), indicating that our future expectations of its dividend payments over the next five years coupled with its net debt position fall far below the cumulative free cash flow that we expect it to generate over the next five years. The company's 7.1% dividend yield may be worth the risk, however. Jan 8, 2024
Thinking Slow: 3 Research Blind Spots That Changed the Investment World
Image Source: EpicTop10.com. We have to be on high alert about how our minds work. PBS recently delivered a four-part series examining how easily our minds are being hacked, and why it is so important to "think slow." When it comes to the active versus passive debate, does the analysis suffer from parameter risk? With respect to empirical, evidence-based analysis, does the analysis have the entire construct wrong? When it comes to short-cut multiples, are we falling into the behavioral trap of thinking on autopilot? Jan 4, 2024
It’s All About Free Cash Flow – Walgreens Cuts Its Payout
Image: Walgreens’ shares have been under consistent pressure for years, and a turnaround is not guaranteed. Today, January 4, Walgreens announced that it would slash its quarterly dividend payment to $0.25 per share, a 48% decrease. This should not be surprising to members. Walgreens’ Dividend Cushion ratio stood at -0.3 (negative 0.3), and we hope members have avoided this catastrophe of a Dividend Aristocrat. A Dividend Cushion ratio below 1 signals increased long-term risk to the payout, while a firmly negative Dividend Cushion ratio signals heightened risk. Our cash-based dividend growth process has led to outperformance in the Dividend Growth Newsletter portfolio the past couple years, while other areas have suffered, and it has also shown to be useful in predicting dividend cuts. Walgreens is now one of more than 50 companies across our coverage universe in recent years where the Dividend Cushion ratio has warned of significant risk to the sustainability of the dividend in advance of the cut. Jan 4, 2024
4 Very Good Reasons Why We Don’t Like Dividends of Banking Stocks
Image: Bank Run in Michigan, USA, February 1933. Source: Public Domain. It’s sometimes easy to lose sight of the fragility of a banking firm’s business model. Let’s examine the reasons why we don’t like banking firms’ dividends. Reason #1: A Bank Run Is Always Possible. Reason #2: Others Have Tried to Invest in Bank Dividends and Have Failed. Reason #3: Cash Flow Is Not Meaningful at Banks. Reason #4: There Are Plenty of Other Options. Let's dig in.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267268269270271272273274275276277278279280 281282283284285286287288289290291292293294295296297298299300 301302303304305306307308309310311312313314315316317318319320 321322323324325326327328329330331332333334335336337338339340 341342343344345346347348349350351352353next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|